
2nd Annual eDiscovery for the Life Science Industry Conference
Enhancing eDiscovery Practices through Risk Mitigation, Implementing Strategies for Cost-Containment and Reducing Volume of Data for Preservation, Collection and Review
February 27-28, 2012 | Philadelphia, PA
Pharmaceutical, biotech, medical device and diagnostic companies have unique regulatory requirements and technologies that impact how they conduct internal investigations caused by regulatory inquires, litigation, antitrust and whistleblowers. The industry uses a variety of resources to conduct the investigation, including internal response teams and outside counsel. With the scope of these investigations often ranging beyond simply reviewing email & created user accounts, extending to enterprise applications for financial and human resource information, file-sharers, document management systems, collaboration tools and structured databases for sales, marketing, research and development and clinical trials, the manner in which these internal investigations are conducted and the tools used requires a tremendous amount of technology and resources where eDiscovery becomes a central tool and asset. With many organizations facing numerous lawsuits based on patent infringement, intellectual property protection or any of the myriad number of regulations they are held accountable for, the use of eDiscovery techniques has become more popular than ever.
TOPICS TO BE COVERED
| And More | |
ADD TO CALENDAR
FOLLOW US ON TWITTER
KEY PRESENTERS INCLUDE
David Waxse
Craig Shaffer
Timothy Hillman
Tom Anderton
Patricia Barbieri
| And More | |
Mailing List Sign-Up
Contact:
Paul Hernandez
Marketing Director
Q1 Productions
500 N. Dearborn
Suite 700
Chicago, IL 60654
312.602.9683 Direct phernandez@q1productions.com



